Vanguard Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,957,417
| Closed | -$90.9M | – | 4605 |
|
|
2023
Q2 | $90.9M | Buy |
1,957,417
+29,161
| +2% | +$1.35M | ﹤0.01% | 1906 |
|
|
2023
Q1 | $55.2M | Buy |
1,928,256
+24,840
| +1% | +$712K | ﹤0.01% | 2132 |
|
|
2022
Q4 | $59.4M | Buy |
1,903,416
+516,658
| +37% | +$16.1M | ﹤0.01% | 2095 |
|
|
2022
Q3 | $28.1M | Buy |
1,386,758
+170,649
| +14% | +$3.46M | ﹤0.01% | 2477 |
|
|
2022
Q2 | $18.9M | Buy |
1,216,109
+619,476
| +104% | +$9.61M | ﹤0.01% | 2667 |
|
|
2022
Q1 | $11.4M | Buy |
596,633
+14,313
| +2% | +$274K | ﹤0.01% | 3079 |
|
|
2021
Q4 | $14.7M | Buy |
+582,320
| New | +$14.7M | ﹤0.01% | 3005 |
|